🔎 Trials Near Me

Beranda › Kanker Endometrium › Maine

Uji klinis Kanker Endometrium di Maine

7 studi untuk Kanker Endometrium mencari peserta di lokasi di Maine.

Kota di Maine

Teks studi resmi (Bahasa Inggris)

Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial

  • Harold Alfond Center for Cancer Care, Augusta
  • Lafayette Family Cancer Center-EMMC, Brewer
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
  • dan 1 lainnya
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT05564377

Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer

  • Lafayette Family Cancer Center-EMMC, Brewer
  • MaineHealth Maine Medical Center- Scarborough, Scarborough
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 2 Okt 2026 · NCT07198074

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

  • MaineHealth Maine Medical Center- Scarborough, Scarborough
Menerima pesertaFase 2
Usia 18 ke atas · Wanita · Diperbarui 28 Sep 2026 · NCT05112601

Endometrial Cancer Vaginal Fluid Specimen Collection Study

  • MaineHealth, Scarborough
Menerima pesertaStudi observasional
Usia 18 ke atas · Wanita · Diperbarui 27 Agu 2026 · NCT07544680

Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)

  • Research Site, Scarborough
Menerima pesertaFase 3
Usia 18 ke atas · Wanita · Diperbarui 29 Jul 2026 · NCT07044336

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scarborough
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.